Question
Explain the mechanism of action of vaccines with reference to the primary and secondary immune responses. How does the concept of immunological memory underlie vaccine effectiveness?
Solution — Step by Step
A vaccine works by presenting the immune system with a harmless form of a pathogen (or part of one) so the body mounts an immune response and develops immunological memory — without ever suffering the actual disease. When the real pathogen arrives later, the body recognises it instantly and destroys it before it can cause illness.
All vaccines exploit one biological fact: the adaptive immune response is faster, stronger, and more targeted the second time it encounters the same antigen.
When the immune system encounters an antigen for the first time (whether from a pathogen or a vaccine), it mounts the primary immune response:
-
Antigen presentation: Macrophages engulf the antigen and display fragments on their surface using MHC class II molecules. This activates helper T cells (CD4⁺).
-
B cell activation: Helper T cells release cytokines that stimulate B cells specific to that antigen. B cells proliferate (clonal expansion).
-
Antibody production: Activated B cells differentiate into plasma cells (effector B cells) that produce antibodies (immunoglobulins). IgM is produced first, then IgG as the response matures.
-
Memory cell formation: Some B cells and T cells differentiate into memory cells — long-lived cells that “remember” the antigen.
Key characteristics: Slow (takes 1–2 weeks), relatively low antibody titre (concentration), short duration. This is why the first infection with a new pathogen makes you sick — the primary response is too slow to prevent disease.
When the same antigen is encountered a second time (either from re-exposure to the pathogen or from a booster vaccine dose):
Memory B cells and memory T cells are already present in large numbers. They respond immediately and vigorously:
- Clonal expansion is much faster (days, not weeks)
- Antibody titre rises to 10–100 times higher than the primary response
- The antibodies produced have higher affinity for the antigen (affinity maturation occurred during the primary response)
- The response persists longer
Key characteristics: Rapid (within 1–3 days), high antibody titre, longer duration, IgG dominant (more protective than IgM).
A vaccine contains antigens in a safe form:
- Live attenuated vaccines (MMR, oral polio, BCG): weakened pathogen that cannot cause disease but is close to the real thing — strong, long-lasting primary response
- Inactivated vaccines (flu shot, injectable polio, hepatitis A): killed pathogen
- Subunit/toxoid vaccines (hepatitis B, HPV, tetanus): just a protein or inactivated toxin from the pathogen
- mRNA vaccines (COVID-19 mRNA vaccines): instructions for cells to make the antigen
The vaccine stimulates the primary immune response and — crucially — generates immunological memory. When the real pathogen arrives, the secondary immune response kicks in so rapidly and powerfully that the pathogen is neutralised before it can multiply to disease-causing levels.
For some vaccines, the primary response fades over time — memory cell populations decline. A booster dose re-exposes the immune system to the antigen, triggering the secondary immune response and refreshing the memory cell pool. This is why tetanus boosters are recommended every 10 years, and why some COVID-19 vaccines required multiple doses.
The first dose primes the immune system (primary response). Subsequent doses boost it (secondary response), resulting in very high antibody titres and durable memory.
Why This Works
The immune system’s memory capacity is the biological rationale for all vaccines. Clonal selection means that when an antigen first activates a B cell, that B cell proliferates and some of its progeny become memory cells. Memory cells are long-lived (years to decades) and low-maintenance. They carry antigen-specific receptors and can be quickly activated. The secondary response is essentially memory cells performing their rapid clonal expansion — they skip the slow naive B cell activation stage entirely.
Herd immunity amplifies this: when enough people in a population are immune, transmission chains break, protecting even non-vaccinated individuals (including infants and immunocompromised patients who cannot be vaccinated).
Alternative Method — Comparison Table
| Feature | Primary Response | Secondary Response |
|---|---|---|
| Timing | 1–2 weeks | 1–3 days |
| Antibody titre | Lower | 10–100× higher |
| Main antibody | IgM then IgG | Predominantly IgG |
| Cells involved | Naive B and T cells | Memory B and T cells |
| Triggered by | First exposure | Second exposure / booster |
| Duration | Shorter | Longer |
Common Mistake
Students often confuse active immunity (body produces its own antibodies — triggered by vaccines and natural infection) with passive immunity (ready-made antibodies given to someone — e.g., anti-tetanus serum, maternal antibodies). Vaccines create active immunity. Passive immunity is immediate but temporary (antibodies are broken down). Active immunity (post-vaccine) is slower to develop but long-lasting.
Also do not say “vaccines contain live pathogens” as a general statement — only live attenuated vaccines do. Many vaccines (inactivated, subunit, mRNA) contain no live organisms at all.
NEET asks: (1) which type of immunity does vaccination produce — active, acquired, artificial; (2) what is immunological memory — memory B and T cells from primary response; (3) difference between IgM and IgG in primary vs secondary — IgM first in primary, IgG dominant in secondary; (4) what is herd immunity threshold. These four points resolve all standard vaccine-related MCQs.